Senestech

Senestech Cash Flow per Share

The Operating Cash Flow per Share of Senestech (SNES) as of Oct 31, 2026 is -1.10 USD. In the previous year, Operating Cash Flow per Share was -8.27 USD — a change of -86.69% (higher).

Cash Flow per Share

-1.10USD

YoY

-86.69%

Last updated:

Operating Cash Flow per Share of Senestech is 2025 -1.10 USD. Operating Cash Flow per Share of Senestech was 2024 -8.27 USD. It decreases by -86.69% higher compared to the previous year.

The Senestech Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
-18,258.00 USD
Jan 1, 2019
-99.98 USD
Jan 1, 2020
-3,384.76 USD
Jan 1, 2021
-1,525.29 USD
Jan 1, 2022
-1,504.74 USD
Jan 1, 2023
-14.72 USD
Jan 1, 2024
-8.27 USD
Jan 1, 2025
-1.10 USD
The Senestech Cash Flow per Share history
YEARCash Flow per ShareYoY
-1.10USD-86.69%
-8.27USD-43.81%
-14.72USD-99.02%
-1,504.74USD-1.35%
-1,525.29USD-54.94%
-3,384.76USD+3,285.60%
-99.98USD-99.45%
-18,258.00USD+7,970.27%
-226.24USD-13.51%
-261.56USD+18.44%
-220.84USD+46,248.27%
-0.48USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Senestech Stock analysis

What does Senestech do? SenesTech, Inc. generates revenue through the sale of ContraPest, a fertility control product targeting rat populations in the pest control industry. ContraPest disrupts reproductive systems in both male and female rats, leading to contraception and eventual sterility. The company's pipeline includes feral animal fertility control for managing feral dogs and hogs in population management, non-surgical spay and neutering for companion dogs and cats in the companion animal health segment, and boar taint solutions for boars in food production and safety. These products are sold to pest control companies, animal health providers, and agricultural businesses. ContraPest is the primary revenue driver, with its application in pest control targeting rat populations. The feral animal fertility control product addresses population management needs for feral dogs and hogs, while non-surgical spay and neutering caters to companion animal health providers. Boar taint solutions are directed at food production companies seeking to improve safety and quality by addressing boar taint in boars. The company's focus on fertility control across multiple segments allows it to serve diverse clients within pest control, animal health, and food production sectors. SenesTech's revenue streams are derived from the commercialization of ContraPest and its pipeline products. ContraPest is sold to pest control businesses for managing rat infestations, while feral animal fertility control is marketed to organizations involved in managing feral animal populations. Non-surgical spay and neutering products target veterinary clinics and pet care providers, and boar taint solutions are sold to food production companies. The company's business model centers on providing fertility control solutions tailored to specific industry needs. Senestech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Senestech stock

Operating Cash Flow per Share of Senestech is -1.10 USD in 2025.

Operating Cash Flow per Share of Senestech changed from -8.27 USD to -1.10 USD, representing a -86.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Senestech since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Senestech

All Key Metrics — Senestech